Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. - Wikidata - awgldk - TriplyDB

Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.

Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.

http://www.wikidata.org/entity/Q35025450

about

Hypertension in Chronic Glomerulonephritis Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC)Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.Multiphoton imaging of the glomerular permeability of angiotensinogen.Translational studies on augmentation of intratubular renin-angiotensin system in hypertension Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.Salt-induced renal injury in SHRs is mediated by AT1 receptor activation.Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.Therapeutic targets for treating fibrotic kidney diseases Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy.Urinary Angiotensinogen as a Novel Biomarker of Intrarenal Renin-Angiotensin System in Chronic Kidney Disease.Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation.Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes.Role of stimulated intrarenal angiotensinogen in hypertension.Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes Circulating and intrarenal renin-angiotensin systems in healthy men and nonpregnant women Increased urinary angiotensinogen precedes the onset of albuminuria in normotensive type 2 diabetic patients.Urinary Angiotensinogen as a Potential Biomarker of Intrarenal Renin-angiotensin System Activity in Chinese Patients with Chronic Kidney Disease.Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy.The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease Angiotensin II blockade and renal protection.Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients.The Effects of Unilateral Nephrectomy on Blood Pressure and Its Circadian Rhythm.Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR rats Urinary markers of intrarenal renin-angiotensin system activity in vivo.Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy.Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension.Role of the intrarenal renin-angiotensin system in the progression of renal disease.Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney.The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients.Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms.Prominent hyperplasia of renin-producing juxtaglomerular apparatus after chronic and complete blockade of the renin-angiotensin system in adult IgA nephropathy.Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

P2860

Q26768702-45B5D414-E762-4D65-B595-4AC34A6A5421 Q28387627-46583B76-5652-4C5F-AF60-24E7CE129D91 Q30491698-1700649A-4531-491B-9114-3773521C18CC Q30527781-33196260-5200-45FD-8A3D-37FFAE71F501 Q33873530-958DF4CA-2373-462E-B1FC-56D564BC1F9A Q33902878-00D8C29D-6459-49C2-AF6D-9F66A4C84403 Q34647857-FC8F7DCE-34EA-4804-A894-95C71DB0382B Q35009712-F66067E0-038E-456F-9AF2-0EC8D9781375 Q35079607-B6625E45-E9B8-43E1-8ED7-26F53EB4F0F3 Q35099739-CE2AC127-38AA-428C-87F7-2659829920AB Q35179398-2D2A93EC-7438-4C84-AA8C-4DFF1F65DE20 Q35245800-B44438A6-0A8A-4AF3-B7A4-78EC160B8C9D Q35528122-CD718251-E007-433B-9334-DB2511D20236 Q35663915-25677277-20FF-4473-9137-C5C73099030F Q35669323-A56308AD-58BF-4ABB-A5F3-0ACF457A3C3B Q35842921-C6593F08-2216-4F1B-A0DD-B9B9B6A1B849 Q36035037-469B48C7-A543-483A-9CF7-9CCD46DB5425 Q36219052-F590F2CA-367B-4A50-9FFE-61EFA03E53EE Q36236725-2A5743D0-DA19-4937-90F9-EFB01B81046D Q36247968-7B17001E-AF62-462C-BA51-F663453481AB Q36261862-815DEBC7-1BCB-43F2-B6AA-52BA9FD17085 Q36306448-EAA0FD34-99F3-44BA-8416-A1C0E22427BA Q36449123-A1F57719-5FA7-413E-AB17-04F52C697F1E Q36561841-826A6A9D-FA23-4962-A850-50AC6F43AEB2 Q36675029-63927317-D858-4732-B1EC-90E07A6596AC Q36836004-4E6B1407-9AC7-4507-88D6-6470B0FD310A Q37465388-741412F7-E4A9-4021-9F9F-80169F5FEFA2 Q37562737-82CA3663-1AA0-4E27-B76D-0F221E460751 Q37564150-2B2A9EBA-E147-4AD9-8BFA-9F67D62C44E0 Q38072329-52F651A1-30B3-4569-A5C4-0B6CC67B10E0 Q38472971-D501E433-C02A-43C3-83C4-227FB769CE14 Q38778217-43EBAE4A-AD34-4ED8-B21F-F2889BAE4E2F Q38886761-ABF8D39E-6970-45E4-A315-23243A9A5AF7 Q39025078-9B2BB9BD-E244-400F-8B57-5637FFAE464C Q40296770-22EE1EEC-5389-49DD-BDF4-F3A218C105BC Q40945376-AA670267-D36B-404D-8C16-53204F8D7CC1 Q41993059-FF9696CC-29C4-4CA2-BC6B-F1CA87F8C44A Q42084094-C29575CB-7276-4C9E-95ED-1430699A2431 Q45801201-5EA97B3F-CDDF-4A82-A1FE-A22B0E265540 Q46159940-07FF89AC-AB77-4399-9C96-7502C9923078

P2860

Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.

http://www.wikidata.org/entity/Q35025450

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Urinary angiotensinogen reflec ...... patients with IgA nephropathy.

@ast

Urinary angiotensinogen reflec ...... patients with IgA nephropathy.

@en

type

label

Urinary angiotensinogen reflec ...... patients with IgA nephropathy.

@ast

Urinary angiotensinogen reflec ...... patients with IgA nephropathy.

@en

prefLabel

Urinary angiotensinogen reflec ...... patients with IgA nephropathy.

@ast

Urinary angiotensinogen reflec ...... patients with IgA nephropathy.

@en

P1433

Q35025450-08B42F68-FC58-4593-8AB3-2C7A515A8231

P1476

Q35025450-A9B93537-E863-481E-A805-4324826F4341

P2093

Q35025450-051107DD-E71F-4F5F-8889-220121977D74

Q35025450-1BC28051-5F4D-46F5-8001-A1F935C125DF

Q35025450-1E4A2A50-C0BF-46FF-97ED-8011E75E9497

Q35025450-21F73DD6-F547-4BC2-A8A9-95FD5172FCC4

Q35025450-44BB9CE0-F221-4FB0-8F3F-3CB8206F950C

Q35025450-4CEA084F-9B2C-4E33-AB59-D6EFC9A30FB9

Q35025450-9C758774-4FC4-4A96-8FA1-101F3FC5AAB3

Q35025450-A3312467-547F-47F0-8613-E84F8A7FDA12

Q35025450-B82412DD-825C-4BD5-87F1-C91B2E69A1EA

Q35025450-D6707792-B80C-4EDB-B7C1-654AD01B5BBE

P2860

Q35025450-0FBC1471-C4E5-4F1D-AAB9-2AD855178934

Q35025450-157C4D77-8694-4937-AFC6-405C79D61B93

Q35025450-2C32F86B-98EA-42CA-8637-568FB89D4F03

Q35025450-2FAEA296-AC24-4594-B75E-CB8E5B94A601

Q35025450-30070778-24A6-455D-B153-478E5F48995C

Q35025450-33FEA6E6-FD2D-44F9-B219-129E4B4DF0CF

Q35025450-34F2180E-1B4E-44B6-AD6E-81F5433C0F29

Q35025450-541CB844-6A22-4CD0-B7E3-E8BBBD847E8B

Q35025450-5D4CC958-C298-49FE-91D7-DEF79C9F0BAD

Q35025450-5DCFDDAF-863B-46A7-A927-D8407D43D00A

P304

Q35025450-A81070B3-CA92-4659-9E6E-3BA508B95FBA

P31

Q35025450-AD8078B5-F91C-45F8-BC49-4C876BEC1C86

P356

Q35025450-5762777F-CE55-4B6B-98E7-AADA600A25C2

P407

Q35025450-940B7E9E-F536-4D7B-90E1-A61088C79B38

P433

Q35025450-9276CD48-1109-4019-9068-63A5BBA52FEA

P478

Q35025450-C43228AB-1E1B-4713-AB15-ECA33B961C74

P50

Q35025450-C9BDC8D3-F9DC-47BD-A2DE-788267885AF9

P577

Q35025450-DF4F9DB1-DD7D-4F62-A4B7-C3822DB796B1

P5875

Q35025450-C6DC8960-25E8-4BD2-8382-A90AC9EF9812

P698

Q35025450-4ADC2A66-3396-46AA-AACD-99582EAFF5C4

P932

Q35025450-C1B2D958-A1B5-47D9-B3DB-845EA70B727A

P356

P1433

Nephrology Dialysis Transplantation

P1476

Urinary angiotensinogen reflec ...... patients with IgA nephropathy

@en

P2093

Akira Nishiyama

http://www.w3.org/2001/XMLSchema#string

Hirofumi Hitomi

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kobori

http://www.w3.org/2001/XMLSchema#string

Maki Urushihara

http://www.w3.org/2001/XMLSchema#string

Masahiro Hamada

http://www.w3.org/2001/XMLSchema#string

Masahito Imanishi

http://www.w3.org/2001/XMLSchema#string

Masatsugu Kishida

http://www.w3.org/2001/XMLSchema#string

Naro Ohashi

http://www.w3.org/2001/XMLSchema#string

Nobuo Shirahashi

http://www.w3.org/2001/XMLSchema#string

Takashi Morikawa

http://www.w3.org/2001/XMLSchema#string

P2860

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Analysis of segmental renal gene expression by laser capture microdissection.

Laser capture microdissection and real-time reverse transcriptase/ polymerase chain reaction of bronchiolar epithelium after bleomycin.

Regulation of intrarenal angiotensin II in hypertension.

ACE inhibitors versus AT(1) receptor antagonists in patients with chronic renal disease.

The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.

Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.

P304

170-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFQ371

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45113452

http://www.w3.org/2001/XMLSchema#string

P698

20615910

http://www.w3.org/2001/XMLSchema#string

P932

3108354

http://www.w3.org/2001/XMLSchema#string